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Hyaluronan (HA)-binding protein 1 (HABP1) is multifunctional
in nature and exists as a trimer through coiled-coil interaction
between α-helices at its N- and C-termini. To investigate the
importance of trimeric assemblage and HA-binding ability of
HABP1, we generated and overexpressed variants of HABP1
by truncating the α-helices at its termini. Subsequently, these
variants were transiently expressed in COS-1 cells to examine
the influence of these structural variations on normal cell morpho-
logy, as compared with those imparted by HABP1. Substantiating
the centrality of coiled-coil interaction for maintaining the tri-
meric assembly of HABP1, we demonstrate that disruption of
trimerization does not alter the affinity of variants towards its
ligand HA. Transient expression of HABP1 altered the morpho-
logy of COS-1 cells by generating numerous cytoplasmic vacuo-
les along with disruption of the f-actin network. Interestingly, the
truncated variants also imparted identical morphological changes.
Characterization of the cytoplasmic vacuoles revealed that most
of these vacuoles were autophagic in nature, resembling those
generated under stress conditions. The identical morphological
changes manifested in COS-1 cells on transient expression of
HABP1 or its variants is attributed to their comparable HA-bind-
ing ability, which in concert with endogenous HABP1, may
deplete the cellular HA pool. Such quenching of HA below a thres-
hold level in the cellular milieu could generate a stress condition,
manifested through cytoplasmic vacuoles and a disassembly of
the f-actin network.
Key words: autophagy, hyaluronan-binding protein 1 (HABP1),
transient expression, truncated variant, vacuole.
INTRODUCTION
Hyaluronan (HA), a high-molecular-mass glycosaminoglycan, is
a principal component of the extracellular matrix of higher ani-
mals. Other than its role in maintaining the matrix structure, HA
is involved in diverse cellular activities such as cellular trans-
formation and proliferation [1], cell locomotion [2], immune re-
actions [3] and developmental processes [4]. HA interacts with
many different proteins collectively called ‘hyaladherins’, which
influence these biological activities [5]. Some of these hyaladhe-
rins are involved in cell–cell or cell–matrix interactions. One such
important hyaladherin, first purified from rat liver, is a 68-kDa
sialic acid containing glycoprotein termed HABP1 (HA-binding
protein 1), having a pI of 4.2 [6]. This cell-surface localized pro-
tein [7] has a role in cellular functions similar to cell adhesion and
tumour invasion [8], sperm maturity and motility [9,10]. The role
of HABP1 in HA-mediated cellular signalling with an increase in
the formation of inositol 1,4,5-trisphosphate and phospholipase
C-γ combined with enhanced phosphorylation of HABP1 in
HA-supplemented cells has already been demonstrated [11].
This protein has been implicated as a substrate for mitogen-
activated protein kinase and its differential localization pattern
under mitogenic stimulation has been shown in normal and trans-
formed fibroblast cells [12]. The cDNA encoding HABP1 from
human fibroblast has been cloned, overexpressed in bacteria and
characterized [13].
Sequence analysis and biochemical studies have identified
numerous homologous or identical genes for HABP1 in eukaryo-
tic species, ranging from fungi to mammals. The identical genes
Abbreviations used: AP, alkaline phosphatase; DIG, digoxigenin; GFP, green fluorescent protein; HA, hyaluronan; HABP1, HA-binding protein 1; MDC,
monodansylcadaverine; PCD, programmed cell death.
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include p32, a protein co-purified with human splicing factor
associated protein (SF2) [14] and gC1qR, receptor for the globular
head of the complement subcomponent C1q [15]. Its homology
was observed with Mam33p, a mitochondrial matrix protein as-
sociated with oxidative phosphorylation in Saccharomyces
cerevisiae [16] and YL2, an HIV-Rev binding murine homologue
[17]. Apart from its ability to bind HA, HABP1 interacts with
numerous cellular proteins including transcription factor II B [18],
the lamin B receptor [19], vitronectin [20], high-molecular-mass
kininogen and factor XII [21]. In addition to cellular proteins,
HABP1 also interacts with numerous pathogenic proteins [22–
26], indicative of its possible role under conditions of pathogenic
stress.
The crystal structure shows it to be a doughnut-shaped homo-
trimer, with a unique non-crystallographic 3-fold axis of sym-
metry [27]. Each monomer has seven consecutive β-strands,
forming a highly twisted antiparallel β-sheet. The β-strands are
flanked by one N-terminal (α-A) and two C-terminal (α-B and
α-C) α-helices, where the N-terminal helix (α-A) forms an anti-
parallel coiled-coil with the C-terminal helix (α-C) of the adjacent
subunit, an interaction responsible for the homotrimerization of
HABP1. Recent studies have reported the formation of a cysteine-
mediated dimer of trimers for HABP1 [28]. Interestingly, the
cDNA sequence reveals the presence of a single cysteine residue
in each protomer in the polypeptide chain of HABP1 [13]. This
oligomerization has functional implications, since the compact
structure appears to have higher affinity for HA [29]. Although the
binding of HABP1 to HA is reported to occur under oligomeric
conditions, interactions of HABP1 with C1q and viral proteins
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Table 1 Primers used for generating the truncated variants of HABP1
The sequence underlined represents the restriction sites. The combinations of primers used for
either amplifying the cDNA or generating the truncated variants of HABP1 are mentioned in the
Materials and methods section.
Primer name Sequence Position Restriction site
S1 5′-ggagatatacatatgcacaccgac-3′ Forward NdeI
S2 5′-gcagccggatcctgtaaactc-3′ Reverse BamHI
S12 5′-ccctccctcatatgtctgga-3′ Forward NdeI
S20 5′-ccccgatatctactcctggtgctccagggc-3′ Reverse EcoRV
have been shown to occur under monomeric conditions as well
[15,22–26].
To investigate the importance of trimeric assemblage and HA
binding, we generated variants of HABP1 by truncating the α-
helices at its N- and C-termini. These PCR-cloned variants were
expressed in Escherichia coli and analysed for their HA-binding
ability. After in vitro analysis, we transiently expressed the trun-
cated variants in COS-1 cells and compared the deviations in cel-
lular morphology from those incurred by HABP1.
MATERIALS AND METHODS
Generation of N- and C-terminal truncated variants
HABP1 cDNA was cloned under the NdeI and BamHI restriction
sites of pET-30b (Novagen) and designated as pET.AS.HABP1.
DNA segments for the truncated variants were generated by PCR
with pET.AS.HABP1 serving as the template. The forward pri-
mers used in the present study had the NdeI site, whereas the re-
verse primer for the N-terminal deleted fragment had a BamHI site
and that for the C-terminal deleted fragment had an EcoRV
site. The primers selected for the study are shown in Table 1. The
S1 and S20 primers were used to generate the C-terminal trun-
cated fragment, whereas S12 and S2 primers were used for
the N-terminal truncated fragment. PCR was performed using
AmpliTaqTM DNA polymerase (PerkinElmer, Norwalk, CT,
U.S.A.) according to the following procedure. For a 50 µl
reaction, 40 ng of template, 0.15 µM of each primer and 0.25 mM
of each dNTP were used. The samples were incubated in a thermal
cycler (MJ Research, Waltham, MA, U.S.A.) at 94 ◦C for 5 min
and then kept for 30 cycles of amplification. Each cycle included
45 s denaturation (94 ◦C), 60 s annealing (55 ◦C) and 90 s chain
elongation (72 ◦C). After 30 cycles, the reaction was extended
for an additional 5 min at 72 ◦C. The N- and the C-terminal
truncated fragments (900 and 600 bp respectively) were purified
using WizardTM SV PCR-purification kit (Promega, Madison, WI,
U.S.A.). The N-terminal truncated fragment was digested with
NdeI and BamHI (New England Biolabs, Beverly, MA, U.S.A.)
and cloned at the NdeI–BamHI restriction sites of pET-30b and
was designated as pET.AS.N.HABP1. The C-terminal truncated
fragment was digested with NdeI and EcoRV and cloned at the
NdeI–EcoRV restriction sites of pET-30b and was designated as
pET.AS.C.HABP1.
Confirmation of the clones
The cloning junction and the presence of both the variants were
confirmed by restriction digestion and Southern hybridization
[30]. The probe used for Southern hybridization was labelled
with DIGTM (digoxigenin). In short, a PCR was performed using
AmpliTaqTM DNA polymerase, according to the following proce-
dure. For a 25 µl reaction, 20 ng of template, 0.15 µM each of
S1 and S20 primers, 0.2 mM dATP, dCTP, dGTP and 0.15 mM
dTTP along with 1 µl of DIG–UTP mixed nucleotide (Roche
Biochemicals, Basel, Switzerland) were used. The PCR cycles
were performed as described previously. The probes were ana-
lysed for the amount of DIG incorporated using standard DIG-
labelled DNA supplied by the manufacturer.
Expression and purification of the recombinant proteins
HABP1 and its variants were overexpressed in E. coli strain
BL21(DE3) and purified by ion-exchange chromatography. A
single E. coli colony was inoculated in 10 ml of Luria–Bertani
medium containing 30 µg/ml kanamycin and grown at 37 ◦C for
9–12 h. Approx. 1% of the cells were inoculated into 100 ml
of Luria–Bertani medium containing 30 µg/ml kanamycin and
grown at 37 ◦C to A600 ∼ 0.6. Protein expression was induced
with 1 mM isopropyl β-D-thiogalactoside. After induction, cells
were grown at 37 ◦C for 3 h and collected by centrifugation. The
bacterial pellet was suspended in 10 ml of buffer A [20 mM Hepes/
1 mM EGTA/1 mM EDTA/5% (v/v) glycerol, pH 7.5] and dis-
rupted by sonication, until it was optically transparent. The cell ex-
tract was centrifuged at 10000 g for 30 min at 4 ◦C to remove
debris. The supernatant was subjected to 30–90% ammonium
sulphate fractionation at 4 ◦C, maintaining the pH between 7.5
and 7.8. The ammonium sulphate precipitate was resuspended in
buffer A and subjected to SDS/PAGE analysis for optimal per-
centage of ammonium sulphate required for the precipitation of
the desired protein. The fractions thus obtained were pooled and
dialysed against 1 litre of buffer A for 16 h. The dialysed sample
was centrifuged at 10000 g at 4 ◦C for 30 min to remove any
particulate matter and then loaded on to Mono-QTM column HR16
(Amersham Biosciences, Uppsala, Sweden), pre-equilibrated
with buffer A. After washing the column with buffer A, the protein
was eluted with 0–1 M sodium chloride gradient, using buffer B
(20 mM Hepes/1 mM EGTA/1 mM EDTA/5% glycerol/1 M
NaCl, pH 7.5). The peak fractions obtained were analysed on
SDS/PAGE and stained with Coomassie Brilliant Blue. Fractions
containing the protein of interest were pooled, desalted and con-
centrated.
Immunoblot analysis
The purified proteins were separated on a 12.5% SDS/poly-
acrylamide gel under reducing conditions and transferred on to a
nitrocellulose membrane [31]. The membrane was blocked for 1 h
with 3% (w/v) BSA in PBS and then incubated with polyclonal
antibodies against HABP1 for 1 h in PBS containing 1.5% BSA.
After washing the blot for 5 × 5 min with PBS supplemented with
0.05% Tween 20 (PBST), it was further incubated for 1 h
with AP (alkaline phosphatase)-conjugated goat anti-rabbit IgG
in 1.5% BSA/PBS. Bound antibodies were detected using Nitro
Blue Tetrazolium/5-bromo-4-chloroindol-3-yl phosphate system
(Amersham Biosciences, Little Chalfont, Bucks., U.K.).
Size-exclusion chromatography
To determine the native molecular mass of HABP1, N.HABP1
and C.HABP1 in solution, gel filtration experiments were
performed on a Superose6TM analytical-grade gel filtration column
interfaced with Pharmacia FPLC system. The column was cali-
brated with the standard proteins aldolase (158 kDa), BSA
(67 kDa), ovalbumin (43 kDa), chymotrypsinogen (25 kDa) and
RNase A (13.7 kDa) (Amersham Biosciences). The buffer used in
the present study was PBS with 150 mM NaCl to keep the ionic
strength constant. The elution speed was kept constant throughout
the experiment at 0.3 ml/min.
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Table 2 Primers used for cloning HABP1 and the truncated fragments into
the mammalian expression vector
The sequence underlined represents the restriction sites.
Primer name Sequence Position Restriction site
Mamm 1 5′-tgtgagcagctgacaattcccctct-3′ Forward PvuII
Mamm 2 5′-gacggagctagcgctcgaattcgg-3′ Reverse NheI
Binding of HABP1 and its variants to immobilized HA
The binding of HABP1 and its variants to immobilized HA was
measured in 96-well microtitre plates (Costar, Cambridge, MA,
U.S.A.). The wells were coated overnight at 4 ◦C with 2 mg/ml
HA in coating buffer (15 mM sodium carbonate and 34 mM
sodium bicarbonate, pH 9.3) and blocked for 2 h in 0.25% BSA
and 0.05% Tween 20 in PBS [32]. After three washes with PBS,
the plates were incubated with the purified proteins for 2 h at room
temperature (24 ◦C). After washing off the unbound proteins, the
plates were incubated with polyclonal anti-HABP1 antibodies for
1 h at room temperature. After 5 × 5 min washes with PBS, the
plates were incubated with AP-conjugated goat anti-rabbit IgG for
1 h at room temperature. After the unbound secondary antibody
was washed off the plates, the reactions were developed using AP-
substrate solution (Sigma 104 phosphate) until the desired colour
developed. The A405 of each well was recorded using a Bio-Rad
microtitre plate reader. For control experiment, immobilized HA
was first overlaid with BSA and subsequently treated with the
antibodies used in the study.
Cloning of HABP1 and its variants into a mammalian
expression vector
The HABP1 cDNA and its variants were cloned in the mammalian
expression vector pBI-EGFP (ClonTech). The fragments were
amplified through PCR using VentTM DNA polymerase (New
England Biolabs) from clones generated in pET-30b and a blunt-
end cloning was made at the PvuII restriction site of pBI-EGFP.
The primers used in the present study are shown in Table 2.
Cell culture and transfection
The origin-defective SV40-transformed green monkey kidney
cells (COS-1), obtained from National Centre for Cell Science
(Pune, Maharashtra, India), were grown in Dulbecco’s modified
Eagle’s medium supplemented with 10% (v/v) foetal calf serum,
100 µg/ml penicillin and 100 µg/ml streptomycin (Invitrogen,
Carlsbad, CA, U.S.A.). Transient transfection in COS-1 cells was
done with LIPOFECTAMINETM 2000 (Invitrogen) according to the
manufacturer’s instructions. For each transfection, 500 ng of kit
purified plasmid DNA (Qiagen GmbH, Hilden, Germany) and
6 µl of LIPOFECTAMINETM 2000 were used. After the transfection
period of 8 h, fresh medium was added and the cells were
grown for an additional 25–30 h. The transfected cells were then
processed for further experiments or imaging.
Analysis of nuclear morphology
For live cells, Hoechst 33342 was added to the medium of trans-
fected cells 1 h before imaging. For fixed cells, after f-actin
detection, the coverslips were washed and stained with Hoechst
in PBS for 15 min in the dark. Thereafter the cells were washed
with PBS and mounted in PBS/glycerol.
Detection of autophagic vacuoles
Autophagic vacuoles were detected with MDC (monodansyl-
cadaverine) by the method of Biederbick et al. [33]. The trans-
fected cells grown for 30 h were washed with PBS to remove
the culture medium. The cells were then incubated with 0.05 mM
MDC in PBS at 37 ◦C for 10 min. After incubation, the cells
were washed four times with PBS and immediately analysed by
fluorescence microscopy.
Examination of f-actin network
For the detection of f-actin, cells were grown on glass coverslips,
fixed with 2% (w/v) paraformaldehyde and washed with PBS.
After permeabilization of the cells with 0.1% Triton X-100, f-
actin was detected by rhodamine–phalloidin (Molecular Probes,
Eugene, OR, U.S.A.). Before mounting, the coverslips were
counter stained with Hoechst.
Microscopy and image analysis
The transfected cells were either used directly for live cell imaging
or analysed after morphological and histochemical detection,
using fluorescence microscopy. The fluorescent cells were viewed
with an Axioscope microscope (Carl Zeiss, Cologne, Germany)
using suitable filter sets, and imaged with the AxioCam camera
system coupled with the AxioVision software (Carl Zeiss).
RESULTS AND DISCUSSION
Generation and purification of the truncated variants of HABP1
To study the structure–function relationship of HABP1, the trun-
cated fragments were generated through PCR. Figure 1(A) sche-
matically represents the cDNA sequence of HABP1 cloned in
pET-30b, depicting the position of primers used for the genera-
tion of the truncated variants. The truncated fragments generated
through PCR were 900 and 600 bp for N.HABP1 and
C.HABP1 respectively, when compared with 1030 bp for
HABP1 (Figure 1B). The fragments were subsequently cloned
in the expression vector pET.30b to generate the truncated
variant constructs, as described in the Materials and methods
section. The cloning junction and the presence of the truncated
variants were confirmed by restriction digestion followed by
Southern hybridization. The restriction digestion profile generated
fragments of 900, 600 and 1030 bp for N.HABP1, C.HABP1
and HABP1 respectively, which could be detected by Southern
hybridization using DIG-labelled cDNA probe, thus establishing
the proper cloning of the fragments (Figures 1C and 1D). The con-
structs were subsequently sequenced to establish their authenticity
(results not shown).
A diagrammatic representation of the variants and their com-
parison with HABP1 is shown in Figure 2(A). The proteins were
successfully overexpressed in E. coli and we have purified the
protein (HABP1), the N-terminal truncated variant (N.HABP1)
and the C-terminal truncated variant (C.HABP1) using an
ion-exchange column on the FPLC. The proteins were purified
to >95% homogeneity, as determined by Coomassie Brilliant
Blue staining of SDS/PAGE, where HABP1, N.HABP1 and
C.HABP1 correspond to 34, 27 and 32 kDa respectively (Fig-
ure 2B). This anomalous migration of HABP1 and its variants
could be attributed to the presence of more than average polar
amino acid residues on these proteins [28]. The calculated pI
values for N.HABP1 and C.HABP1 were 4.05 and 4.21 res-
pectively. The antigenic specificity of the proteins was examined
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Figure 1 Generation and confirmation of the truncated variants of HABP1
(A) A schematic representation of HABP1 variants generated in the present study. The position of primers on the cDNA template is shown, and the first amino acid in the coding region (ATG) and the
termination codon (TAG) have been marked in the scheme. (B) pET.AS.HABP1 was used as the template for PCR, using the primer combinations mentioned in the Materials and methods section,
whereas pET-30b in combination with S1–S2 primers was used as a negative control. The amplified products were analysed on a 1.2 % (w/v) agarose gel alongside 1 kb DNA molecular-mass
standards (Invitrogen). The amplified fragments in each lane are marked with an arrow. (C) HABP1 and the truncated fragments, cloned in pET-30b, were digested with NdeI and BamHI restriction
endonucleases and resolved on a 1.5 % agarose gel. The fragment generated from HABP1 was 1030 bp in length, whereas those from N.HABP1 and C.HABP1 were 900 and 600 bp respectively.
(D) Southern hybridization using DIG-labelled cDNA probe specifically detected the fragments, thus establishing their proper cloning.
Figure 2 Purification and immunodetection of the truncated proteins
(A) HABP1 and its variants are schematically depicted indicating the HA-binding motif (shaded).
The amino acids 74–104 of HABP1 have been deleted to generate N.HABP1, whereas amino
acids 268–282 have been deleted to generate C.HABP1. In C.HABP1, a stop codon has been
introduced after Glu-267. In the recombinant protein, Leu-74 has been replaced with Met-74.
(B) HABP1, N.HABP1 and C.HABP1 were purified and resolved by SDS/PAGE (12.5 % gel)
followed by staining with Coomassie Brilliant Blue to analyse their subunit molecular mass.
(C) The proteins were transferred on to nitrocellulose membrane and immunodetected by Western
blotting using polyclonal anti-HABP1 antibodies.
by immunodetection using anti-HABP1 polyclonal antibodies
(Figure 2C), which clearly demonstrated antigenic similarity of
the variants to HABP1.
Truncation of terminal helices of HABP1 abolishes
oligomerization
Oligomeric states of HABP1 and its variants were examined
by size-exclusion chromatography. Standard proteins used for
the calibration of the column have been marked 1–5, depicting
aldolase, BSA, ovalbumin, chymotrypsinogen and RNase A
respectively (Figure 3A). HABP1 exists primarily as a trimer
in equilibrium with disulphide-mediated dimer of trimer, exhibi-
ting trimeric and hexameric molecular masses of 68 and 136 kDa
under non-reducing gel filtration chromatography. The variants
exhibited the presence of monomeric and dimeric forms corres-
ponding to 20 and 40 kDa for N.HABP1 and 22 and 44 kDa for
C.HABP1 under non-reducing gel filtration chromatography
(Figure 3B). However, under reducing conditions (0.02% 2-mer-
captoethanol), N.HABP1 and C.HABP1 exhibited mono-
meric species only (Figure 3C), whereas HABP1 exhibits only
the trimeric species. These results substantiate that truncation at
either N- or C-terminal generates variants, which are incapable
of forming a trimer by coiled-coil interaction of the α-helices.
It also shows that under normal or physiological conditions, the
variants tend to form a disulphide linkage, giving rise to the dimer
apart from the monomer, whereas HABP1 exists primarily as tri-
mer and hexamer under such conditions. The two forms, the disul-
phide-linked dimer as well as the monomer, exist in equilibrium.
These observations are consistent with our earlier report of con-
formational flexibility of HABP1 [29].
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Figure 3 Truncation of terminal helices of HABP1 abolishes oligomerization
(A) The elution profile of the column calibration markers, plotted against the logarithm
of molecular mass. The calibration markers, aldolase (158 kDa), BSA (67 kDa), ovalbumin
(43 kDa), chymotrypsinogen (25 kDa) and RNase A (13.7 kDa) are labelled through 1–5, in
the order of decreasing molecular mass and the same labelling is followed throughout. The
gel filtration analysis of HABP1 (––), N.HABP1 (- - - -) and C.HABP1 (– – – –) were
performed under (B) non-reducing conditions and (C) reducing conditions (in the presence of
0.2 % 2-mercaptoethanol).
HA-binding ability of the variants is comparable with HABP1
Earlier studies from our laboratory have already shown that
HABP1 binds HA under trimeric or hexameric conditions [28].
However, the variants do not possess this trimeric assembly,
as evident from the size-exclusion chromatography results (Fig-
ure 3). The HA-binding ability of each variant was examined using
immobilized HA. ELISA strips coated with HA were overlaid
with protein sample and detected using antibodies, as described
in the Materials and methods section. Results indicate that both
N.HABP1 and C.HABP1 effectively bind to HA (Figure 4)
and their binding efficiency is comparable with HABP1. Thus
although terminal deletions alter the oligomerization property of
the variants, they retain their ability to bind HA. This suggests that
although the variants have an altered structure, their HA-binding
Figure 4 HA-binding ability of the variants is comparablewith that of HABP1
Immobilized HA on ELISA plates was used to compare the HA-binding ability of N.HABP1
() and C.HABP1 (H17009) with that of HABP1 (). The proteins (in PBS) were overlaid on
immobilized HA under non-reducing conditions. The background reading for the control (BSA)
has been subtracted from the experimental samples. Results represent the average of duplicate
determinations in at least three identical experiments, performed under similar conditions.
motif remains accessible to the solvent, a proposition reflected in
their HA-binding ability. This motif remains unaltered in variants
and dimerization of the variants may juxtapose each monomer in
a manner that allows it to be accessible for binding. From this
observation, it appears that the juxtaposition of the HA-binding
motif may be a predominant influence for HA binding rather than
just the oligomeric structure and compactness of HABP1.
Expression of HABP1 and its variants in COS-1 cells induces
identical morphological changes
To compare the morphological and cellular changes imparted by
HABP1 and its variants, the cDNA were cloned in the mammalian
expression vector pBI-EGFP and expressed in COS-1 cells. The
bi-directional vector pBI-EGFP aided us in evaluating the cellular
morphology of living cells, as GFP (green fluorescent protein)
would distribute uniformly in the cell and divulge visible changes
thereof. The constructs were authenticated for their orientation
in pBI-EGFP and then transiently expressed in COS-1 cells.
The vector pBI-EGFP, expressing GFP, served as control for all
comparative analysis. Although no visible change in the shape and
size of the cells was evident, the transfected cells exhibited altered
morphology, with numerous conspicuous cytoplasmic caveolar-
like circular structures resembling vacuoles (Figure 5A). These
structures have been henceforth referred to as ‘vacuoles’. The cells
were stained with Hoechst for visualizing the nucleus, whereas
the presence of GFP facilitated cell-morphology analysis in living
cells. These results are in agreement with our earlier reports, where
the formation of similar cytoplasmic vacuoles has been shown
in a cell lines stably expressing HABP1 [34]. The presence of
small vacuoles in cultured cell lines is not an unknown feature;
however, owing to an increase in the size and the number of
vacuoles after transient expression of the proteins, a statistical
analysis (n = 10) of each clone was performed. This was done
to estimate whether the vacuole formation was an artifact of
transfection or a morphological manifestation of cellular changes
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Figure 5 Expression of HABP1 and its variants induce identical
morphological changes
(A) The COS-1 cells transfected with (a) pBI-EGFP showed less vacuole formation when
compared with cells transfected with (b) HABP1, (c) N.HABP1 or (d) C.HABP1. The Figure
shows representative images for each sample. The first column shows the morphology as
depicted by the distribution of GFP, whereas the second column reveals cell nuclei, visualized
through Hoechst staining. The third column shows the superimposed images corresponding to
GFP and Hoechst merged together. The conspicuous vacuoles have been labelled with an arrow.
Scale bar, 10 µm. (B) A statistical analysis for the percentage of vacuole-bearing cells in the
transfected population, as compared with the vector control. Results represent means +− S.D.
for ten independent experiments for each clone.
due to expression of the proteins. These results revealed a 4-fold
increase in the percentage of transfected cells harbouring vacuoles
in cells expressing HABP1 or its variants (Figure 5B). However,
it needs to be emphasized that vacuole formation was not an
inherent manifestation of plasmid transfection or GFP expression,
as evident from the percentage of cells exhibiting them.
Figure 6 Detection of autophagic vacuoles through MDC in the transfected
cells
MDC staining of the conspicuous vacuoles reveal them to be both autophagic (white arrows) and
non-autophagic (white arrowheads) in nature. The cells transfected with HABP1 (ii), N.HABP1
(iii) and C.HABP1 (iv) reveal increased autophagic vacuoles, when compared with the vector
(i). The Figure shows representative images for each sample. The first column shows the
morphology of the transfected cells, as depicted by the distribution of GFP, whereas the second
column reveals autophagic vacuoles, visualized through MDC staining. The third column shows
the superimposed images corresponding to GFP and MDC merged together. Scale bar, 10 µm.
The generation of conspicuous cytoplasmic vacuoles after tran-
sient expression of HABP1 or its variants prompted us to char-
acterize their nature. In general, cytoplasmic vacuoles are often
autophagic in nature. Transfected cells were stained with MDC
as it has been successfully used in determining autophagic vac-
uole [35]. Results reveal the population of vacuoles to be hetero-
geneous, being both autophagic and non-autophagic in nature
(Figure 6). However, MDC staining reveals that the cells tran-
siently expressing HABP1 or its variants show more prominent
autophagic vacuoles, when compared with the vector control,
indicating that these autophagic vacuoles were not an outcome
of GFP expression but a consequence of expression of HABP1
or it variants. Autophagy has been considered as an adaptive res-
ponse to nutrient deprivation, stress conditions, tissue-specific
biogenesis and a housekeeping mechanism involved in cyto-
plasmic homoeostasis, as it controls the turnover of peroxisomes,
mitochondria and the size of the endoplasmic reticulum [36].
Earlier studies on autophagic vacuoles have established their
acidic nature [37,38]. HABP1 and its variants manifest pI of
approx. 4; consequently, their acidic nature makes them probable
candidates for entry into the vacuoles. Stress conditions often
lead to the formation of autophagic vacuoles [35,39] and transient
expression of HABP1 or its variants in COS-1 cells might evoke
a similar phenomenon, forcing the cells to take up autophagy as
an adaptive response. Autophagy is also involved in maintaining
a balance between protein synthesis and degradation [40] and is
often associated with stress conditions and diseased states, leading
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Figure 7 Examination of the f-actin network in the transfected cells
Rhodamine–phalloidin staining of the transfected cells revealed a disassembly of the f-actin network. The cells transfected with HABP1 (b), N.HABP1 (c) and C.HABP1 (d) reveal f-actin
aggregation around the nucleus and it appears disassembled, with a distinct disruption at the vacuolar region, when compared with the vector (a). The conspicuous vacuoles are marked with an arrow.
The Figure shows representative images for each sample. The first column shows the morphology of the transfected cells, as depicted by the distribution of GFP; the second column reveals f-actin
network, detected through rhodamine–phalloidin staining; whereas the third column reveals nuclear morphology, visualized through Hoechst staining. The superimposed images corresponding to
GFP, rhodamine and Hoechst, merged together, are shown in the third column. Scale bar, 15 µm.
to PCD (programmed cell death) [41]. HABP1 is a constitutive
multifunctional protein and its transient expression in cells might
interfere with the functioning of endogenous HABP1, altering the
cellular homoeostasis and affecting stress conditions, which leads
to the generation of vacuoles. The formation of vacuoles might
indicate PCD and cells manifesting them may undergo such a
process soon thereafter, as already shown by our earlier studies
on cell lines stably expressing HABP1 [34].
A cytoskeletal network is an integral feature of all cells, and
its disruption often reflects a departure from normal cellular
behaviour. Therefore, in supporting experiments, the fate of
f-actin was studied to observe any alteration in cytoskeletal net-
work resulting from the transient expression of HABP1 or its
variants. As evident from Figure 7, the cells transiently expres-
sing HABP1 or its variants disrupted the f-actin network, a key
component of the cytoskeleton. F-actin appeared to aggregate
around the nucleus, with a distinct disassembly at the vacuolar
region. Cytoskeletal proteins are often associated with PCD and
the disruption of the microfilament network or depolymerization
of f-actin in cell death has already been shown [42,43]. In ac-
cordance with this, our investigation on f-actin in cells transiently
expressing HABP1 or its variants indicated a disassembly in the
network. Taken together, our observations indicate that the ex-
pression of HABP1 or its truncated variants in cultured mam-
malian cells impart identical morphological changes.
Conclusion
Although earlier studies have established that trimerization of
HABP1 is critical for HA binding, the present observations reveal
that a juxtaposition of the HA-binding motif may play a dominant
role in this phenomenon. We have shown that HABP1 and its
variants bind HA with comparable affinity and their expression
induces identical cytoplasmic vacuoles and a disruption of f-actin
network in cultured mammalian cells. Most of these vacuoles,
apparently generated through stress conditions, have been shown
to be autophagic in nature. These identical morphological changes
imparted by the transient expression of HABP1 or its variants
appear to be due to their comparable HA affinity rather than
their structural variations. In the light of the present observations,
we hypothesize that the overall increase in the level of cellular
HABP1 (expressed and endogenous) beyond the housekeeping
requirement may deplete the cellular ‘HA pool’ to such a critical
extent that it results in the generation of a stress condition
c© 2004 Biochemical Society
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leading to the formation of vacuoles. Therefore, in principle, the
orchestration of ‘HA pool’ by hyaladherins appears to play a key
role in regulating the cellular functions of HA.
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